Lanreotide Autogel in the Treatment of Idiopathic Refractory Diarrhea: Results of an Exploratory, Controlled, Before and After, Open-label, Multicenter, Prospective Clinical Trial
Chronic idiopathic diarrhea is the passage of loose stools >3 times daily, or a stool weight >200 g/d. Patients refractory to standard anti-diarrhetic have limited treatment options. Somatostatin analogs have the ability to reduce gastrointestinal secretions and motility.

Related Post